Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × daromun × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 4 Sarcoma 1

Conditions

Sarcoma, Kaposi 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1

Interventions

pembrolizumab 2 tocilizumab 1 poly ICLC 1 flt3 ligand protein 1 daromun 1 Specimen Handling 1 SUB1 protein, human 1 Radiotherapy 1 Radiation 1 Nivolumab 1 Mohs Surgery 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 IPI-926 1 Capecitabine 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05329792 2023-10-06

IntriNSiC

Philogen S.p.A.

Phase 2 Unknown

DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Sarcoma, Kaposi, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡